7 Results

People

  1. Lavery
    Lavery
  2. Arcila
    Arcila
  3. Barker
    Barker
  4. Benayed
    Benayed
  5. Berger
    Berger
  6. Bhuiya
    Bhuiya
  7. Borrill
    Borrill
  8. Brannon
    Brannon
  9. Broach
    Broach
  10. Brown
    Brown

Groups

  1. Department of Medicine (6)
  2. Hematologic Malignancies, Division of (4)
  3. Population Sciences Research Program (4)
  4. Solid Tumor Oncology Division (4)
  5. Biostatistics Service (3)
  6. Center for Hematologic Malignancies (3)
  7. Epidemiology and Biostatistics (3)
  8. GSK Faculty (3)
  9. Survivorship Research (3)
  10. CTCR Scholars (2)
  1. "adult"
  2. "Jessica Lavery"
Formats
  1. Journal Article (6)
  2. Review (1)
Groups
  1. Department of Medicine (6)
  2. Hematologic Malignancies, Division of (4)
  3. Population Sciences Research Program (4)
  4. Solid Tumor Oncology Division (4)
  5. Biostatistics Service (3)
  6. Center for Hematologic Malignancies (3)

More Groups

People
  1. Jessica Lavery (7)
  2. Aaron Lisman (1)
  3. Aaron Praiss (1)
  4. Ahmet Zehir (1)
  5. Alexia Iasonos (1)
  6. Andrew Kung (1)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (2)
Publications
  1. BMJ Open (1)
  2. Blood Advances (1)
  3. Cancer Discovery (1)
  4. Gynecologic Oncology (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. Journal of Immigrant and Minority Health (1)

More Publications

Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Hematology (1)
  3. BMJ Publishing Group Ltd. (1)
  4. Biomed Central Ltd (1)
  5. Elsevier Inc. (1)
  6. Springer (1)

More Publishers

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Leave it in the past - Primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Sia, T. Y.; Manning-Geist, B. L.; Ehmann, S.; Lavery, J. A.; Luardo, C.; Praiss, A.; Iasonos, A.; Sonoda, Y.; Grisham, R. N.; Liu, Y. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Characteristics of cancer hospitals with written language access policies
    Journal Article

    Kung, A.; Li, D. G.; Lavery, J. A.; Narang, B.; Diamond, L.
    Journal of Immigrant and Minority Health (2023)

    Fulltext@MSK | Save
  • AACR project GENIE: 100,000 cases and beyond
    Journal Article

    Pugh, T. J.; Bell, J. L.; Bruce, J. P.; Doherty, G. J.; Galvin, M.; Green, M. F.; Hunter-Zinck, H.; Kumari, P.; Lenoue-Newton, M. L.; Li, M. M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Comparing the reporting and conduct quality of exercise and pharmacological randomised controlled trials: A systematic review
    Review

    Adams, S. C.; McMillan, J.; Salline, K.; Lavery, J.; Moskowitz, C. S.; Matsoukas, K.; Chen, M. M. Z.; Santa Mina, D.; Scott, J. M.; Jones, L. W.
    BMJ Open (2021)

    Fulltext@MSK | Save
  • Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia
    Journal Article

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors
    Journal Article

    Mamoor, M.; Postow, M. A.; Lavery, J. A.; Baxi, S. S.; Khan, N.; Mao, J. J.; Rogak, L. J.; Sidlow, R.; Thom, B.; Wolchok, J. A.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Robust CD4(+) T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin
    Journal Article

    Politikos, I.; Lavery, J. A.; Hilden, P.; Cho, C.; Borrill, T.; Maloy, M. A.; Giralt, S. A.; van den Brink, M. R. M.; Perales, M. A.; Barker, J. N.
    Blood Advances (2020)

    Fulltext@MSK | Save